Physician Agency and Competition: Evidence from a Major Change to Medicare Chemotherapy Reimbursement Policy
We investigate the role of physician agency and competition in determining health care supply and patient outcomes.
We investigate the role of physician agency and competition in determining health care supply and patient outcomes.
Health care in the United States is more expensive than in other developed countries, costing $2.7 trillion in 2011, or 17.9 percent of the national gross domestic product.
With quality-of-care bonus payments now available for Medicare Advantage health maintenance organizations (HMOs) and for accountable care organizations in traditional Medicare, the need to under
Objective: Medicare Part D provides formulary protections for antipsychotics but does not exempt these drugs from cost-sharing.
Identifying policies that will cut or constrain US health care spending and spending growth dominates reform efforts, yet little is known about whether the drivers of spending levels and of spending g
The article focuses on a study which examined the effects of the expanding Medicaid coverage for low-income adults in the U.S. using the 2008 Medicaid expansion in Oregon.
Enrollment in Medicare Advantage, the managed care program for Medicare beneficiaries, has grown rapidly, from 4.6 million enrollees in 2003 to 12.8 million by 2012, or 27 percent of all current
Health plans participating in the Medicare managed care program, called Medicare Advantage since 2003, have historically attracted healthier enrollees than has the traditional fee-for-service program.
Within Medicare, the Medicare Advantage program has historically attracted better risks—healthier, lower-cost patients—than has traditional Medicare.
Get smart & reliable public policy insights right in your inbox.